Acasă › Insuficiență cardiacă › Ohio › Cincinnati
Studii clinice pentru Insuficiență cardiacă în Cincinnati, OH
24 studii pentru Insuficiență cardiacă caută participanți în și în jurul orașului Cincinnati (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
În curs de recrutareFaza 3
- Research Site, Cincinnati
- Research Site, Cincinnati
BiVACOR® Total Artificial Heart Early Feasibility Study
În curs de recrutare
- The Christ Hospital, Cincinnati
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
În curs de recrutareFaza 3
- The Lindner Research Center at the Christ Hospital, Cincinnati
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
În curs de recrutare
- The Christ Hospital, Cincinnati
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
În curs de recrutareFaza 3
- Research Site, Cincinnati
- Research Site, Cincinnati
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
În curs de recrutareFaza 3
- Cincinnati, OH Investigative Site 10088, Cincinnati
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
În curs de recrutare
- The Christ Hospital - Cincinnati, Cincinnati
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
În curs de recrutareFaza 2
- Local Institution - 129, Cincinnati
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
În curs de recrutareFaza 2/3
- Cincinnati Children's Hospital Medical Center ( Site 0034), Cincinnati
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
În curs de recrutareFaza 2
- The Lindner Center for Research & Education at The Christ Hospital, Cincinnati
NORM-HF Pivotal Study
În curs de recrutare
- Christ Hospital Lindner, Cincinnati
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Cincinnati Childrens Hospital Medical Center, Cincinnati
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
În curs de recrutareStudiu observațional
- Cincinnati, Cincinnati
- Edgewood, Edgewood · La 8 mi distanță
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
În curs de recrutareStudiu observațional
- Christ Hospital Health Network, Cincinnati
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
În curs de recrutareFaza 3
- Lindner Center,Christ Hospital, Cincinnati
Alleviant ALLAY-HF Study
În curs de recrutare
- St. Elizabeth Healthcare, Edgewood · La 8 mi distanță
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
În curs de recrutareFaza 3
- FIN- 10112, Cincinnati, OH, Cincinnati
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
În curs de recrutareFaza 3
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
În curs de recrutare
- The Christ Hospital- Cincinnati, Cincinnati
- University of Cincinnati, Cincinnati
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
În curs de recrutareFaza 3
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
În curs de recrutare
- Christ Hospital, Cincinnati
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
În curs de recrutare
- Lindner Research Center at the Christ Hospital, Cincinnati
Left vs Left Randomized Clinical Trial
În curs de recrutare
- The Christ Hospital, Cincinnati
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
În curs de recrutareStudiu observațional
- The Lindner Research Center at The Christ Hospital, Cincinnati
- St. Elizabeth Healthcare, Edgewood · La 8 mi distanță
Studii pentru Insuficiență cardiacă în alte orașe
- New York City, NY51 studii
- Boston, MA44 studii
- Dallas, TX42 studii
- Houston, TX36 studii
- Cleveland, OH33 studii
- Chicago, IL31 studii
- Philadelphia, PA31 studii
- San Francisco, CA29 studii
- St. Louis, MO26 studii
- Durham, NC26 studii
- Atlanta, GA25 studii
- Kansas City, MO25 studii
Alte studii în Cincinnati
- Cancer pulmonar cu celule non-pătrate35 studii
- Cancer (toate tipurile)27 studii
- Cancer de sân25 studii
- Cancer colorectal21 studii
- Leucemie mieloasă acută20 studii
- Cancer metastatic20 studii
- Cancer ovarian19 studii
- Cancer pulmonar19 studii
- Obezitate19 studii
- Cancer de prostată18 studii
- Mielom multiplu17 studii
- Melanom17 studii
Sursă: ClinicalTrials.gov, date preluate la 4 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.